arrow
S

Stuart A. Scott

Stanford University
H指数:63
被引数:1.6万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

De Novo Variants Associated With Autosomal Recessive Conditions: Case Series and Implications for Genetic Testing and Counseling

常染色体隐性条件相关的全新变异:病例系列及其对遗传检测和咨询的启示

2026-09-010
PRE
Biallelic Variants in RNU6ATAC Result in a Minor Spliceopathy Characterized by Transcriptome-Wide Minor Intron Retention Events and Short Stature with Variable Multisystem Manifestations

RNU6ATAC基因的双等位基因变异导致一种次要剪接障碍,其特征为转录组范围的次要内含子滞留事件、身材矮小以及多变的全身性表现。

2026-03-090
OAAI
Drivers of differential antibody breadth in SARS-CoV-2 mRNA vaccination and infection

SARS-CoV-2 mRNA疫苗接种和感染中差异抗体宽度的驱动因素

2025-11-010
PRE
Transcriptome-wide outlier approach identifies individuals with minor spliceopathies

转录组范围离群值方法识别具有微小剪接病变的个体

2025-09-190
OA
Progress in Pharmacogenomics Implementation in the United States: Barrier Erosion and Remaining Challenges

美国药物基因组学实施进展:障碍侵蚀与遗留挑战

2025-06-040
OAAI
Discovery of ancestry-specific variants associated with clopidogrel response among Caribbean Hispanics

加勒比西班牙裔中与氯吡格雷反应相关的祖源特异性变异的发现

2025-03-070
OA
A Joint Consensus Recommendation of the Association for Molecular Pathology, Clinical Pharmacogenetics Implementation Consortium, College of American Pathologists, Dutch Pharmacogenetics Working Group of the Royal Dutch Pharmacists Association, European Society for Pharmacogenomics and Personalized Therapy, and Pharmacogenomics Knowledgebase
2023-09-0130
OAAI
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A Genotypes and Serotonin Reuptake Inhibitor Antidepressants

CYP2D6,CYP2C19,CYP2B6,SLC6A4和HTR2A基因型和5-羟色胺再摄取抑制剂抗抑郁药的临床药物遗传学实施联盟 (CPIC) 指南

2023-05-30138
OAAI